The effect of Hypbaric oxygen therapy in the treatment of hidradenitis suppurativa: a randomised controlled trial

The effect of Hypbaric oxygen therapy in the treatment of hidradenitis suppurativa: a randomised controlled trial - HBOT in HS

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON55331

Enrollment

100

Registered

2020-12-17

Start date

2022-05-08

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acne inversa fox-den disease

Interventions

In combination with standard care (lifestyle advice, medication, potential operation as seen suitable by the treating doctor), 20 sessions of 2 hours HBOT (5 days per week for 4 weeks). Any operatio

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Hurley stage IIB,IIc or III, men and women aged 18-60

Exclusion criteria

Exclusion criteria: History of pneumothorax, lung emphysema Current otitis media Inability to equalise ear pressure

Design outcomes

Primary

Measure	Time frame
Do HBOT improve wound healing in HS lesions? Outcome parameters: Hurley staging, Hidradenitis Suppurativa clinical response score, wound size reduction	—

Secondary

Measure	Time frame
Does HBOT improve the quality of life in HS patients? Outcome parameter: dermatology quality of life index	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)